2022 AHA/ACC/HFSA Heart Failure Management Guidelines – Value Statements


2022 AHA/ACC/HFSA Heart Failure Management Guidelines – Value Statements

This infographic outlines the economic value statements from the 2022 AHA/ACC/HFSA guidelines for heart failure management, helping to prioritize recommendations based on cost-effectiveness and quality of life impact. It categorizes treatments into high, intermediate, and low economic value, aiding clinicians in delivering cost-effective care. This includes guidelines for both medications and devices, ensuring a balanced approach to managing symptomatic chronic heart failure with reduced ejection fraction (HFrEF).

Produced by: Dr. Saahil Jumkhawala
Edited by: Dr. Teodora Donisan


CardioNerds Infographics

Explore our comprehensive collection of infographics, categorized by cardiovascular topics such as heart failure and transplantation, arrhythmias and electrophysiology, cardio-obstetrics, cardiovascular imaging, congenital heart disease, prevention, coronary artery disease, critical care, hypertension, pericardial disease, pulmonary hypertension, valvular heart disease, vascular disease, women’s cardiovascular health, diversity, inclusion, and more!

Feel free to download and share these visuals in presentations or on social media. Please use the infographics as provided—without altering or cropping out the creators’ credit.

For even more learning, explore the CardioNerds Tweetorial Page, featuring a curated collection of educational tweetorials!

You are currently viewing 2022 AHA/ACC/HFSA Heart Failure Management Guidelines – Value Statements